EPPI-Reviewer is a web-based systematic review platform developed and maintained by the EPPI-Centre (Evidence for Policy and Practice Information and Co-ordinating Centre) at the UCL Social Research Institute, University College London. It is one of the longest-established tools in the systematic review software market, growing out of more than a decade of the EPPI-Centre’s own review work on public policy questions before being offered as a hosted service to outside review teams. Unlike most other commercial screening platforms, EPPI-Reviewer is run as a not-for-profit service: UCL states that the fees it charges are “a contribution to our costs for infrastructure, development and support” rather than a profit-driven subscription.
What EPPI-Reviewer does
EPPI-Reviewer covers the full evidence-synthesis pipeline in one connected workspace, from reference import and screening through data extraction, quality/risk-of-bias appraisal, and synthesis — the stages a PRISMA 2020-reported review needs to document. It stores and lets reviewers annotate PDF full texts directly inside the platform, and it supports both quantitative synthesis (including meta-analysis, which draws on R software under the hood) and qualitative and mixed-methods synthesis approaches such as framework synthesis and thematic synthesis — a combination narrower screening-only tools generally do not offer.
- Text-mining and machine-learning classifiers. EPPI-Reviewer includes an “active learning” mode for citation screening, where the system continually re-ranks the unscreened queue based on the inclusion/exclusion decisions reviewers have already made, surfacing likely-relevant records earlier. It also ships pre-built machine-learning classifiers that can flag records likely to be randomized controlled trials, systematic reviews, or economic evaluations, and it allows a review team to train its own classifier from its own screening decisions.
- Living systematic reviews and evidence maps. A review can “subscribe” to an ongoing update service that uses machine learning — trained on the studies already included — to flag new, potentially relevant literature as it is published, which is the mechanism the platform uses to support living systematic reviews and living evidence maps rather than one-off, time-limited searches.
- Structured, form-based data extraction and coding. Data extraction and thematic coding run through configurable structured forms rather than free-text notes or spreadsheets, keeping extracted fields consistent across every included study and supporting the two-stage “map, then synthesize in depth” approach the EPPI-Centre developed from its own policy-review practice.
- Qualitative and mixed-methods synthesis. EPPI-Reviewer’s support for meta-ethnography, framework synthesis, and other qualitative synthesis methods, alongside conventional meta-analysis, is one of its more distinctive features among the mainstream systematic-review platforms — most competitors are built primarily around quantitative, intervention-effectiveness reviews.
Who actually uses EPPI-Reviewer
Because of its roots in the EPPI-Centre’s own work, EPPI-Reviewer is used heavily for reviews that inform public policy and practice — questions about the effectiveness, feasibility, implementation, and acceptability of interventions in areas such as education, social welfare, public health, and international development. It is also used more broadly by academic review teams, including in health and clinical fields, who need a platform that can handle qualitative or mixed-methods synthesis alongside conventional meta-analysis, or who want the “map first, then synthesize a subset in depth” workflow the tool was built around.
Pricing and access
EPPI-Reviewer runs on a subscription-fee model administered directly by the EPPI-Centre, rather than the per-seat or per-review commercial licensing common among other vendors in this space. UCL is explicit that this is a not-for-profit, cost-recovery arrangement rather than a commercial product line. The platform’s own site notes that only a modern web browser (Chrome, Firefox, Edge, or Safari) and an internet connection are needed to use it, and it offers trial access — check the EPPI-Reviewer site directly for current fee structure and trial terms, since pricing details change and CASRAI does not intermediate vendor billing.
How EPPI-Reviewer compares to other screening and review tools
EPPI-Reviewer sits alongside a small set of other platforms that review teams choose between depending on review type, budget, and how much of the pipeline they need one tool to cover. For a full side-by-side across the whole systematic-review software landscape — full-workflow platforms and screening-only tools, commercial and free/open-source — see CASRAI’s Systematic Literature Review Tools comparison guide. Two of the other tools covered there also have their own dedicated CASRAI guides:
- DistillerSR is a commercial platform from Evidence Partners positioned toward high-volume, regulated review work — pharmacovigilance, HTA/HEOR, and regulatory dossiers — with a heavier emphasis on validated audit trails and configurable workflow governance than EPPI-Reviewer’s not-for-profit, policy-research-oriented model.
- ASReview is a free, open-source screening tool built around active-learning prioritization, similar in spirit to EPPI-Reviewer’s active-learning screening mode but narrower in scope — ASReview focuses on the screening stage rather than covering extraction, appraisal, and qualitative synthesis in the same platform.
In practice, EPPI-Reviewer’s main differentiator is breadth: it is one of the few platforms that natively supports qualitative and mixed-methods synthesis (meta-ethnography, framework synthesis) in the same tool as quantitative meta-analysis, screening, and extraction, which matters most for review teams working across intervention-effectiveness and implementation questions rather than a single quantitative outcome.
Frequently asked questions
Who develops EPPI-Reviewer?
The EPPI-Centre at the UCL Social Research Institute, part of University College London’s Institute of Education. It is run as a not-for-profit, cost-recovery service rather than a commercial product.
Is EPPI-Reviewer free?
No — it runs on a subscription-fee model, though the EPPI-Centre positions the fees as covering infrastructure, development, and support costs rather than generating profit, and trial access is available. Check the EPPI-Reviewer site directly for current pricing.
Does EPPI-Reviewer support qualitative synthesis, or only meta-analysis?
Both. EPPI-Reviewer supports quantitative meta-analysis (built on R) as well as qualitative and mixed-methods synthesis approaches such as meta-ethnography and framework synthesis — a combination most other mainstream systematic-review platforms do not offer in a single tool.
What is a “living systematic review” in EPPI-Reviewer, and how does it work?
A living systematic review in EPPI-Reviewer is one that “subscribes” to an ongoing update service: the platform’s machine-learning classifier, trained on the studies already included in the review, continually screens newly published literature and flags records likely to meet the review’s inclusion criteria, rather than requiring a fresh manual search each time the review is updated.
How does EPPI-Reviewer differ from DistillerSR or ASReview?
DistillerSR is a commercial platform aimed at high-volume, regulated review work with heavier audit-trail and workflow-governance features. ASReview is a free, open-source tool focused specifically on active-learning screening rather than the full extraction-through-synthesis pipeline. EPPI-Reviewer is a not-for-profit, subscription-funded platform from UCL that covers the full pipeline and is distinctive for its native support of qualitative and mixed-methods synthesis alongside meta-analysis. See the full Systematic Literature Review Tools comparison for a complete feature-by-feature breakdown.
